Affiliation:
1. Tianjin Medical University General Hospital
2. Henan Provincial People's Hospital, the Affiliated People's Hospital of Zhengzhou University
3. Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China
Abstract
Abstract
Purpose
This study aimed to develop and validate a novel nomogram risk assessment model to predict the possibility of type II endoleak (T2EL)-related re-intervention.
Methods and materials:
The data of 455 patients with abdominal aortic aneurysms who underwent elective endovascular aneurysm repair (EVAR) procedures between January 2018 and December 2021 at our single center were retrospectively reviewed. Following the implementation of exclusion criteria, 283 patients were finally included and divided into T2EL-related re-intervention (n = 42) and non-T2EL (n = 241) groups.
Results
The overall T2EL-related re-intervention rate for 283 patients was 14.8% (42/283). Using multivariate analysis, significant risk factors for re-intervention included age (OR, 1.104; 95% CI, 1.023–1.191; P = 0.011), smoking (OR, 4.249; 95% CI, 1.383–13.052; P = 0.012), hypertension (OR, 4.175; 95% CI, 1.321–13.192; P = 0.015), and number of patent lumbar arteries (OR, 6.270; 95% CI, 3.030–12.974; P < 0.001). The discrimination ability of this risk-predictive model was reasonable (concordance index [C-index] = 0.886; 95% CI, 0.825–0.947). The Hosmer-Lemeshow goodness of fit test was performed on the model, and the chi-square value was 13.832 (P = 0.086), presenting an excellent agreement between the model-predicted and observed values. The receiver operating characteristic (ROC) curve identified that the risk thresholds of re-intervention were a diameter of > 2.77 mm for the diameter of the inferior mesenteric artery and a proportion of < 45.5% for thrombus volume in the aneurysm sac.
Conclusion
This novel nomogram risk assessment model for predicting the possibility of patients’ T2EL-related re-interventions after EVAR should be helpful in discriminating high-risk patients. Two novel risk thresholds may imply a higher possibility of T2EL-related re-intervention after EVAR.
Publisher
Research Square Platform LLC